BMRN

60.4301.61%
CH

Cristin Hubbard

Executive VP & Chief Commercial Officer

Ms. Cristin Hubbard was Senior Vice President of Immunology, Infectious Disease & Ophthalmology, Global Product Strategy at Hemlibra at Roche Holding AG and served as its Lifecycle Leader. She serves as Executive VP & Chief Commercial Officer at BioMarin Pharmaceutical Inc. since May 20, 2024. She has experience in the biopharmaceutical and diagnostics industries. She served as the head of Global Product Strategy for Roche Pharma, where she was responsible for lifecycle management, accelerating delivery of the company's medicines from development to commercialization, across five therapeutic areas. She was also accountable for delivering portfolio prioritization and integrated strategic plans across the company's entire portfolio. Prior to that, she served as global head of Diagnostics Partnering for Roche Diagnostics, with responsibility for driving growth through licensing deals and acquisitions. At Roche and Genentech, she served in a number of senior roles across therapeutic areas, including immunology, infectious disease, oncology, ophthalmology and hemophilia. She started her career as a medicinal chemist at Theravance, before joining Roche and Genentech. She holds a bachelor's degree in Biochemistry and Molecular Biology from the University of California, Santa Cruz. She also completed the Graduate Program of Health Management at the University of California, Berkeley, earning an MBA from the Haas School of Business and an MPH from the School of Public Health.

Positions